Optimal Cytoreductive Surgery Is an Independent Prognostic Indicator in Stage IV Epithelial Ovarian Cancer with Hepatic Metastases

Author： Naik R. Nordin A. Cross P.A. Hemming D. de Barros Lopes A. Monaghan J.M.

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.78, Iss.2, 2000-08, pp. : 171-175

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytoreductive Surgery for the Management of Stage IV Ovarian Cancer

By Schwartz P.E.

Gynecologic Oncology, Vol. 64, Iss. 1, 1997-01 ,pp. : 1-3

Elsevier

Access to resources Recommend Favorite

Prognostic Factors of Stage IV Epithelial Ovarian Cancer: A Multicenter Retrospective Study

By Akahira J.-I. Yoshikawa H. Shimizu Y. Tsunematsu R. Hirakawa T. Kuramoto H. Shiromizu K. Kuzuya K. Kamura T. Kikuchi Y. Kodama S. Yamamoto K. Sato S.

Gynecologic Oncology, Vol. 81, Iss. 3, 2001-06 ,pp. : 398-403

Elsevier

Access to resources Recommend Favorite

Prognostic Significance of Residual Disease in Patients with Stage IV Epithelial Ovarian Cancer

By Munkarah A.R. Hallum A.V. Morris M. Burke T.W. Levenback C. Atkinson E.N. Wharton J.T. Gershenson D.M.

Gynecologic Oncology, Vol. 64, Iss. 1, 1997-01 ,pp. : 13-17

Elsevier

Access to resources Recommend Favorite

Cytoreductive Surgery for Ovarian Cancer

By Omura G.A.

Gynecologic Oncology, Vol. 80, Iss. 2, 2001-02 ,pp. : 332-332

Elsevier

Access to resources Recommend Favorite

Secondary Cytoreductive Surgery for Localized Intra-abdominal Recurrences in Epithelial Ovarian Cancer

By Munkarah A. Levenback C. Wolf J.K. Bodurka-Bevers D. Tortolero-Luna G. Morris R.T. Gershenson D.M.

Gynecologic Oncology, Vol. 81, Iss. 2, 2001-05 ,pp. : 237-241

Elsevier

Access to resources Recommend Favorite